TTOOT2 Biosystems, Inc.
0.0002USD0.00%Mkt Cap: 5609 USDP/E: Last update: 2026-05-25

T2 Biosystems, Inc. engages in the development and commercialization of medical diagnostic products for critical unmet needs in the healthcare. Its products include T2Dx instrument, T2Candida panel, and T2Bacteria panel.…

Indicators:|

Key Statistics

Company
Market Cap5.61K USD
Enterprise Value16.87M USD
Revenue (TTM)7.68M USD
Gross Profit-8.17M USD
Net Income (TTM)-50.08M USD
Revenue/Share0.7290 USD
Last Price0.0002 USD
Fiscal Year EndDec 2023
MR QuarterSep 2024
Employees113
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISINUS89853L2034
Valuation
P/E (Trailing)
P/E (Forward)-0.00
PEG
EV/EBITDA-0.41
EV/Revenue2.20
P/S0.00
P/B-0.00
EPS (TTM)-0.03
EPS (Forward)-1.19
52W Range
0.00010% of range0.1650
52W High0.1650 USD
52W Low0.0001 USD
Profitability
Gross Margin-113.58%
Oper. Margin-511.89%
EBITDA Margin0.00%
Profit Margin-696.19%
ROE178.62%
ROA-143.91%
Growth
Revenue Growth34.90%
Earnings Growth
Cash Flow & Leverage
Operating CF-48.14M USD
CapEx (TTM)192.00K USD
FCF Margin-343.45%
FCF Yield-470081.58%
Net Debt16.86M USD
Net Debt/EBITDA-0.41
Balance Sheet
Debt/Equity-1.77
Current Ratio0.40
Quick Ratio0.17
Book Value/Sh-0.6240 USD
Cash/Share0.0990 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:100
Split DateOct 13, 2023
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.28.05M
Float11.90M
Insiders5.38%
Institutions0.00%
Short Interest
Short Ratio0.7d
Short % Float4.87%
Short % Out.3.02%
Shares Short846.14K
Short (prev mo.)942.49K
Technical
SMA 500.0011 (-81.5%)
SMA 2000.0067 (-97.0%)
Beta8.26
S&P 52W Chg28.31%
Avg Vol (30d)4.43K
Avg Vol (10d)1.29K
Technical Indicators
RSI (14)
MACD
MACD Signal
MACD Hist.
BB Upper
BB Middle
BB Lower
BB Width
ATR (14)
Vol Ratio (20d)